Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s Accelerated Approval Council: Bigger Role, More Transparency Coming?
Jan 27 2025
•
By
Sue Sutter
The expedited withdrawal procedures were pressure-tested by Pepaxto in 2024.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Pink Sheet Perspectives
More from Pathways & Standards